Read + Share
Amedeo Smart
Independent Medical Education
Bu K, Patel D, Morris R, Han W, et al. Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System. J Alzheimers Dis 2022 Aug 6. pii: JAD220583. doi: 10.3233/JAD-220583.PMID: 35964196
Email
LinkedIn
Facebook
Twitter
Privacy Policy